samedan logo
 
 
 
spacer
home > ebr > autumn 2001 > medicon valley - the scandinavian hotspot
PUBLICATIONS
European Biopharmaceutical Review

Medicon Valley - The Scandinavian Hotspot

Medicon Valley encompasses Skåne in southern Sweden and Copenhagen in Denmark, and is home to no less than 60 per cent of Scandinavia's biotechnology and pharmaceutical industries. More than 54,000 people in Medicon Valley work within the medical industry, including 5,000 researchers.Medicon Valley ranks number three in Europe in the biomedicine field, after London and Paris, and the region has probably the highest number of biotech companies per capita in the world. Sweden and Denmark are ranked number two and three in Europe when it comes to R&D expenditure per capita in the pharmaceutical industry, and Denmark and Sweden are, per capita, ranked number three and five in terms of world pharmaceutical exports. Medicon Valley has ample capital for biotechnology projects and also has patient investors who think long-term. In 1994, US$250 million was available to Medicon Valley. By 2000, this figure had increased to US$650 million and the invested capital in Medicon Valley was approximately US$160 million.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Ulf Åberg, Managing Director of Region Skåne

Ulf Åberg is currently Managing Director of Region Skåne. He completed his education at MBA Lund University, and at the Nordic Institute for Planning. After graduating, Ulf spent 15 years in leading positions in the regional economic development field, and a further five years working in Latin America for various international organisations.
Some of the positions he has held have included: Director of Planning on Malmöhus County Administrative Board; Director of Planning on Skåne County Administrative Board; and Director of Trade and Industry Department in Region Skåne. Ulf has also served as a Member of the Board of Directors of Teknopol AB, Euro Info Syd AB, and Öresund Identity Network.

spacer
Ulf Åberg
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

IBM Research and Arctoris Accelerate Closed Loop Drug Discovery with AI and Cloud

Oxford and Zurich – 13 September 2021 – Life Science Newswire – Today, IBM Research and Arctoris announced they are investigating the application of AI and automation to accelerate closed loop molecule discovery. IBM Research has developed RXN for Chemistry, an online platform leveraging state-of-the-art Natural Language Processing (NLP) architectures to automate synthetic chemistry.
More info >>

White Papers

Utilising Big Data to Produce Faster and Cheaper Clinical Research

Medical Research Network (MRN) Limited

Recruitment and retention of patients remains the major challenge to ensuring trials run as fast as possible and give them the statistical power they are designed to produce. This is not just about getting better any more - but about stopping the deterioration of these metrics in modern clinical trials.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement